MedPath

Olprinone

Generic Name
Olprinone
Drug Type
Small Molecule
Chemical Formula
C14H10N4O
CAS Number
106730-54-5
Unique Ingredient Identifier
4Y8BMI9YGC

Overview

No overview information available.

Background

No background information available.

Indication

用于使用其他药物疗效不佳的急性心力衰竭的短期静脉治疗。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Olprinone Hydrochloride Injection
国药准字H20150028
化学药品
注射剂
2/21/2020
Olprinone Hydrochloride Injection
国药准字H20233906
化学药品
注射剂
6/30/2023
Olprinone Hydrochloride Injection
国药准字H20233032
化学药品
注射剂
1/10/2023
Olprinone Hydrochloride Injection
国药准字H20223294
化学药品
注射剂
5/10/2022
Olprinone Hydrochloride Injection
国药准字H20234703
化学药品
注射剂
12/26/2023
Olprinone Hydrochloride Injection
国药准字H20223940
化学药品
注射剂
12/30/2022
Olprinone Hydrochloride Injection
国药准字H20223671
化学药品
注射剂
2/2/2023
Olprinone Hydrochloride Injection
国药准字H20223273
化学药品
注射剂
4/29/2022
Olprinone Hydrochloride Injection
国药准字H20233477
化学药品
注射剂
12/18/2023
Olprinone Hydrochloride Injection
国药准字H20223247
化学药品
注射剂
4/19/2022

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath